Amaranth Medical is dedicated to advancing the field of interventional cardiology through the development of the thinnest bioresorbable drug eluting scaffolds that perform like metallic stents. Our latest investigational scaffold, MAGNITUDE®, was designed using our proprietary bioresorbable technology and from the learnings of our first and second generation devices, FORTITUDE® and APTITUDE®, respectively. With sizes in the sub-100 µm range, MAGNITUDE® is the thinnest bioresorbable scaffold developed to date.
Our proprietary bioresorbable technology platform is designed to be as thin and strong as metal stents with all of the advantages of bioresorption.1
Amaranth Medical In The News
Amaranth Presented MAGNITUDE (98 micron) Nine-Month Follow-up Clinical Results and Introduced DEFIANCE (85 micron) BRS Development Plan at TCT
Amaranth Presented Interim Nine-Month Follow-up MAGNITUDE (98 micron) and Two-Year Follow-up APTITUDE (115 micron) Data at EuroPCR Symposium